Please login to the form below

Not currently logged in
Email:
Password:

autoimmune conditions

This page shows the latest autoimmune conditions news and features for those working in and with pharma, biotech and healthcare.

Microsoft brings machine learning to genetics collaboration

Microsoft brings machine learning to genetics collaboration

Chad Robins, Adaptive’s president, CEO and co-founder, said: “Some conditions like cancer or autoimmune disorders can be difficult to diagnose, but this universal map of the immune system will

Latest news

  • UCB collaborates with UK's Medical Research Council UCB collaborates with UK's Medical Research Council

    Since the first approval of a therapeutic monoclonal antibody over 30 years ago, antibodies have become key therapies in a range of disease areas including autoimmune conditions, infections and cancer.

  • Lilly pays Nektar $150m upfront for phase I autoimmune drug Lilly pays Nektar $150m upfront for phase I autoimmune drug

    It has the potential to be a first-in-class therapy for the millions of people around the world with autoimmune diseases such as lupus, Crohn’s disease, psoriasis and rheumatoid ... This could lead to a profound clinical impact and healthy organ

  • Sanofi and Ablynx sign €2.4bn nanobody deal Sanofi and Ablynx sign €2.4bn nanobody deal

    Through external partnerships like these, combined with our internal R&D expertise, we aim to transform the treatment landscape for patients living with autoimmune and inflammatory conditions.”.

  • Celgene uses 'video views' map in arthritis awareness drive Celgene uses 'video views' map in arthritis awareness drive

    Also, many disclose that their PsA is confused with osteoarthritis - also known as 'age-related' or 'wear and tear' arthritis-and other autoimmune conditions. ... However, PsA is a disease that is different from other arthritic or psoriatic conditions

  • Janssen partners with Isis on stomach conditions Janssen partners with Isis on stomach conditions

    Will develop treatments that target RNA in people with autoimmune disorders. ... The two companies will focus on developing so-called'antisense' drugs that bind to the genetic sequence of a faulty gene in order to treat autoimmune disorders that affect

More from news
Approximately 2 fully matching, plus 12 partially matching documents found.

Latest Intelligence

  • Managing medication non-adherence Managing medication non-adherence

    Autoimmune conditions such as Crohn’s disease can flare up through an imbalance of things like stress, lack of sleep or overworking - not just as a direct consequence of nonadherence to ... The latter is a vital service for patients with chronic

  • Taking a lean and careful approach Taking a lean and careful approach

    This fits well with our mission to tackle unmet needs. Autoimmune conditions are increasing and diabetes is at epidemic levels. ... A lot of NASH patients also have these conditions so we want to look at and understand the underlying causes to see what

  • Deal Watch table for April 2014 Deal Watch table for April 2014

    7, 100. Questcor/ Mallinckrodt. Acquisition. Acthar Gel (repository corticotropin) for “difficult-to-treat” autoimmune/ inflammatory conditions.

  • Pharma deals during April 2014 Pharma deals during April 2014

    premium. This gives Mallinckrodt, Acthar Gel (repository corticotropin), which is FDA approved for 19 “difficult-to-treat” autoimmune and inflammatory associated conditions and currently primarily used to treat multiple sclerosis relapses,

  • Deal Watch table for June 2013 Deal Watch table for June 2013

    165. Novartis / Questcor. Development rights. Rights to develop Synacthen (tetracosactide,   melanocortin receptor agonist) and Synacthen Depot (approved in Europe for autoimmune &inflammatory conditions).

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Patient Persepective: Autoimmune Disease

    Autoimmune diseases affect 1–5% of the World’s population and have varied symptoms and causes. ... Here we explore with Lois what it is like to live with the symptoms of autoimmune disease, including Crohn’s disease, a form of inflammatory bowel

More from PMHub
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hayward Medical Communications

Hayward Medical Communications has been supporting partners in every sector of the healthcare industry to deliver evidence-based, clinically relevant and...

Latest intelligence

Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...

Infographics